Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
about
Secretion properties, clearance, and therapy in airway diseaseInhaled mannitol for cystic fibrosisInhaled mannitol for cystic fibrosisAirway Epithelial Cell Cilia and Obstructive Lung DiseaseEffectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasisAnalysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis.Neutrophilic inflammation is associated with altered airway hydration in stable asthmaticsBronchiectasis--diagnosis and treatmentMucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.A year in review: Respirology 2005 - clinical science.Evaluation and management of patients with pulmonary nontuberculous mycobacterial infections.Inhaled mannitol in cystic fibrosis.New treatment options for bronchiectasis.Inhaled mannitol for the treatment of cystic fibrosis.Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.Emerging drugs for bronchiectasis.Effect of inhaled dry powder mannitol on mucus and its clearance.Host mucin glycosylation plays a role in bacterial adhesion in lungs of individuals with cystic fibrosis.Bronchiectasis: an update on current pharmacotherapy and future perspectives.Developing drug therapies in bronchiectasis.Emerging drugs for bronchiectasis: an update.Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.Hypertonic saline therapy in cystic fibrosis: Evidence against the proposed mechanism involving aquaporins.Bronchiectasis, part 2: Management.Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis.A pediatric disease to keep in mind: diagnostic tools and management of bronchiectasis in pediatric age.Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial.
P2860
Q21195704-9DE1EBB2-6311-4743-A286-1CCF5E6960D9Q24186558-2D622F65-F2EC-40FB-BC63-3799A47D2507Q24236723-DFC31FC2-2862-40D5-9F97-B4F2D34BF6EFQ28074301-4A7DD13A-A4F6-4E31-BE11-D3C30001AC52Q31114718-2623FD43-EBDC-4414-80C7-72F83A1FD50DQ33555044-A0FF2E69-FFD8-4E7A-96AC-8FE352DBE03CQ33636016-849E8EE9-BCAC-4860-AFA4-98960E42474DQ35628004-0F51EFD6-BDD6-4298-9FC5-E8B49377B77EQ36053855-69C3123C-E0E7-414C-8D0C-9E353F3BB68DQ36372618-EC2BB86E-E121-458B-B476-FE4749DB3F04Q36688950-D6677CEC-63B6-46D8-A561-81F74AE594FCQ36861632-E7AD3FDC-954D-4533-880C-3CEAF9B73D79Q37730295-1B2E1DAC-179D-4739-9FBB-8FC31CB871D8Q37979246-6BA6D861-FFEF-4B64-8FE9-AB631C572269Q38007997-FA08BF30-8A07-4912-9C92-FCCC434BC631Q38027233-D730037F-4206-4850-B239-2AA77CED238BQ38077798-0EBE0DA6-0A0B-41DE-A131-CAB0FE7D2690Q38153821-B6D71AB4-F6E2-47E9-AF94-9A2BB06E059BQ38177329-6C6D17FE-43A4-48B6-A192-99C222376F73Q38259329-472D5D97-A27F-47AA-8948-05338E1DDC44Q38367379-F9DE8E12-0EC9-4055-A25E-A93ECBB57DB8Q41729344-1EB89269-3790-4180-9E1F-CF7768AD9E93Q42497993-786CFA5A-8D63-4D29-88E0-43EC3429A0ADQ42945234-726FD230-C5D3-426E-BB18-C482C96943DEQ44780772-A6052E58-5FDF-40A1-82F2-A890FCFAB98EQ46274587-2EDF9061-93FE-4087-BA74-2877527CE111Q48333448-E5ACCF02-819E-4025-B6F7-CD48C0D65F35Q48335145-C421E069-E38E-4F97-B1A2-C3A0190CB027Q55400151-45E69A33-7083-4D76-9E3F-877457522598
P2860
Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Inhaled mannitol for the treat ...... ion, health status and sputum.
@en
Inhaled mannitol for the treat ...... ion, health status and sputum.
@nl
type
label
Inhaled mannitol for the treat ...... ion, health status and sputum.
@en
Inhaled mannitol for the treat ...... ion, health status and sputum.
@nl
prefLabel
Inhaled mannitol for the treat ...... ion, health status and sputum.
@en
Inhaled mannitol for the treat ...... ion, health status and sputum.
@nl
P2093
P2860
P1433
P1476
Inhaled mannitol for the treat ...... ion, health status and sputum.
@en
P2093
Belinda Cochrane
Bruce K Rubin
Evangelia Daviskas
Iven H Young
Kerry Gomes
Peter Briffa
P2860
P356
10.1111/J.1440-1843.2005.00659.X
P577
2005-01-01T00:00:00Z